SK Bioscience Valuation
| 302440 Stock | 48,400 1,550 3.10% |
At this time, the company appears to be overvalued. SK Bioscience owns a latest Real Value of USD42849.5 per share. The recent price of the company is USD48400.0. Our model measures the value of SK Bioscience from examining the company fundamentals such as Profit Margin of 0.36 %, return on equity of 0.18, and Current Valuation of 5.52 T as well as evaluating its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that SK Bioscience's price fluctuation is very steady at this time. Calculation of the real value of SK Bioscience is based on 3 months time horizon. Increasing SK Bioscience's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since SK Bioscience is currently traded on the exchange, buyers and sellers on that exchange determine the market value of 302440 Stock. However, SK Bioscience's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 48400.0 | Real 42849.5 | Hype 48400.0 | Naive 51160.77 |
The real value of 302440 Stock, also known as its intrinsic value, is the underlying worth of SK Bioscience Company, which is reflected in its stock price. It is based on SK Bioscience's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of SK Bioscience's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of SK Bioscience Co helps investors to forecast how 302440 stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of SK Bioscience more accurately as focusing exclusively on SK Bioscience's fundamentals will not take into account other important factors: SK Bioscience Total Value Analysis
SK Bioscience Co is presently forecasted to have takeover price of 5.52 T with market capitalization of 5.56 T, debt of 35.5 B, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the SK Bioscience fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
5.52 T | 5.56 T | 35.5 B |
SK Bioscience Investor Information
About 69.0% of the company shares are owned by insiders or employees . The company recorded earning per share (EPS) of 917.26. SK Bioscience had not issued any dividends in recent years. Based on the measurements of operating efficiency obtained from SK Bioscience's historical financial statements, SK Bioscience Co is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.SK Bioscience Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. SK Bioscience has an asset utilization ratio of 44.03 percent. This suggests that the Company is making USD0.44 for each dollar of assets. An increasing asset utilization means that SK Bioscience Co is more efficient with each dollar of assets it utilizes for everyday operations.SK Bioscience Ownership Allocation
SK Bioscience secures a total of 76.78 Million outstanding shares. SK Bioscience owns majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 69.27 % of SK Bioscience Co outstanding shares that are owned by insiders indicates they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company retains, if the real value of the company is less than the current market value, you may not be able to make money on it.SK Bioscience Profitability Analysis
The company reported the revenue of 929 B. Net Income was 355.14 B with profit before overhead, payroll, taxes, and interest of 570.03 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates SK Bioscience's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in SK Bioscience and how it compares across the competition.
About SK Bioscience Valuation
The stock valuation mechanism determines SK Bioscience's current worth on a weekly basis. Our valuation model uses a comparative analysis of SK Bioscience. We calculate exposure to SK Bioscience's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of SK Bioscience's related companies.8 Steps to conduct SK Bioscience's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates SK Bioscience's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct SK Bioscience's valuation analysis, follow these 8 steps:- Gather financial information: Obtain SK Bioscience's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine SK Bioscience's revenue streams: Identify SK Bioscience's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research SK Bioscience's industry and market trends, including the size of the market, growth rate, and competition.
- Establish SK Bioscience's growth potential: Evaluate SK Bioscience's management, business model, and growth potential.
- Determine SK Bioscience's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate SK Bioscience's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for 302440 Stock analysis
When running SK Bioscience's price analysis, check to measure SK Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SK Bioscience is operating at the current time. Most of SK Bioscience's value examination focuses on studying past and present price action to predict the probability of SK Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SK Bioscience's price. Additionally, you may evaluate how the addition of SK Bioscience to your portfolios can decrease your overall portfolio volatility.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |